ciprofloxacin has been researched along with Hematologic Diseases in 7 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Hematologic Diseases: Disorders of the blood and blood forming tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study was designed to evaluate the benefit of intravenous ciprofloxacin for neutropenic patients with fever who were refractory to initial therapy given for the first 3 days." | 9.12 | Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy. ( Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K, 2006) |
| "Fifty-three granulocytopenic patients were studied in a randomized trial comparing trimethoprim-sulfamethoxaxole (ST) alone with ST + ciprofloxacin (CPFX) for prevention of bacterial infections." | 9.08 | [Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin]. ( Murase, T, 1995) |
| "We compared the combination of teicoplanin plus ciprofloxacin with gentamicin plus piperacillin for the empirical treatment of fever in 80 neutropenic patients." | 9.06 | A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients. ( Collins, PW; Delord, C; Kelsey, SM; Newland, AC; Weinhard, B, 1990) |
| " The present study was designed to evaluate the benefit of intravenous ciprofloxacin for neutropenic patients with fever who were refractory to initial therapy given for the first 3 days." | 5.12 | Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy. ( Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K, 2006) |
| "Fifty-three granulocytopenic patients were studied in a randomized trial comparing trimethoprim-sulfamethoxaxole (ST) alone with ST + ciprofloxacin (CPFX) for prevention of bacterial infections." | 5.08 | [Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin]. ( Murase, T, 1995) |
| "More patients receiving ciprofloxacin did not develop fever during neutropenia and did not receive antibiotics (34%) compared with those receiving norfloxacin (25%) (P = 0." | 5.07 | Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. ( , 1991) |
| "We compared the combination of teicoplanin plus ciprofloxacin with gentamicin plus piperacillin for the empirical treatment of fever in 80 neutropenic patients." | 5.06 | A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients. ( Collins, PW; Delord, C; Kelsey, SM; Newland, AC; Weinhard, B, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mooij, MJ | 1 |
| Schouten, I | 1 |
| Vos, G | 1 |
| Van Belkum, A | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Savelkoul, PH | 1 |
| Schultsz, C | 1 |
| Matsuoka, H | 1 |
| Tsukamoto, A | 1 |
| Shirahashi, A | 1 |
| Koga, S | 1 |
| Suzushima, H | 1 |
| Shibata, K | 1 |
| Uozumi, K | 1 |
| Yamashita, K | 1 |
| Okamura, S | 1 |
| Kawano, F | 1 |
| Tamura, K | 1 |
| Murase, T | 1 |
| Raza, A | 1 |
| Qawi, H | 1 |
| Lisak, L | 1 |
| Andric, T | 1 |
| Dar, S | 1 |
| Andrews, C | 1 |
| Venugopal, P | 1 |
| Gezer, S | 1 |
| Gregory, S | 1 |
| Loew, J | 1 |
| Robin, E | 1 |
| Rifkin, S | 1 |
| Hsu, WT | 1 |
| Huang, RW | 1 |
| Piccolomini, R | 1 |
| Di Girolamo, A | 1 |
| Iacone, A | 1 |
| Fioritoni, G | 1 |
| Cellini, L | 1 |
| Nicoletti, M | 1 |
| D'Antonio, D | 1 |
| Kelsey, SM | 1 |
| Collins, PW | 1 |
| Delord, C | 1 |
| Weinhard, B | 1 |
| Newland, AC | 1 |
5 trials available for ciprofloxacin and Hematologic Diseases
| Article | Year |
|---|---|
Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
Topics: Adult; Aged; Algorithms; Carbapenems; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hemato | 2006 |
[Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infect | 1995 |
Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients.
Topics: Adult; Aged; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Female; Gram-Negative Bacteria; G | 1991 |
Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Female; Fever; | 1991 |
A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; D | 1990 |
2 other studies available for ciprofloxacin and Hematologic Diseases
| Article | Year |
|---|---|
Class 1 integrons in ciprofloxacin-resistant Escherichia coli strains from two Dutch hospitals.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; DNA Fingerprinting; DNA Gyrase; DNA, Bac | 2005 |
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Anorexia; Antineoplastic Combined Chemotherapy Protocols | 2000 |